Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Pascal Vranckx, Marco Valgimigli, Peter Jüni, +197

The Lancet

Endovascular TechniqueCardiovascular DiseaseRandomised Superiority TrialLumen-apposing Metal StentPharmacotherapy +6

Expert recommendations on the assessment of wall shear stress in human coronary arteries: existing methodologies, technical considerations, and clinical applications

Frank Gijsen, Yuki Katagiri, Peter Barlis, +26

European Heart Journal

Vascular DiseaseCardiovascular DiseaseExpert RecommendationsCoronary Artery DiseaseHuman Coronary Arteries +6

Coronary computed tomography angiography for heart team decision-making in multivessel coronary artery disease

Carlos Collet, Yoshinobu Onuma, Daniele Andreini, +23

European Heart Journal

Vulnerable plaques and patients: state-of-the-art

Mariusz Tomaniak, Yuki Katagiri, Rodrigo Modolo, +20

European Heart Journal

Vascular DiseaseSignificant StenosisCoronary Artery DiseaseAcute Myocardial InfarctionInflammation +15

Fractional Flow Reserve Derived From Computed Tomographic Angiography in Patients With Multivessel CAD

Carlos Collet, Yosuke Miyazaki, Nicola Ryan, +24

Journal of the American College of Cardiology

Vascular ImageHealth SciencesMedical ImagingCardiovascular DiseaseMedicine +10

Clinical Implication of Quantitative Flow Ratio After Percutaneous Coronary Intervention for 3-Vessel Disease

Norihiro Kogame, Kuniaki Takahashi, Mariusz Tomaniak, +19

JACC: Cardiovascular Interventions

Percutaneous Coronary InterventionCardiovascular DiseaseClinical ImplicationBlood Flow MeasurementBlood Flow +8

Impact of Fractional Flow Reserve Derived From Coronary Computed Tomography Angiography on Heart Team Treatment Decision-Making in Patients With Multivessel Coronary Artery Disease

Daniele Andreini, Rodrigo Modolo, Yuki Katagiri, +28

Circulation Cardiovascular Interventions

A sirolimus-eluting bioabsorbable polymer-coated stent (MiStent) versus an everolimus-eluting durable polymer stent (Xience) after percutaneous coronary intervention (DESSOLVE III): a randomised, single-blind, multicentre, non-inferiority, phase 3 trial

Robbert J. de Winter, Yuki Katagiri, Taku Asano, +23

The Lancet

Percutaneous Coronary InterventionCardiovascular DiseaseLumen-apposing Metal StentSurgeryBiomedical Engineering +5

Angiography-Derived Fractional Flow Reserve in the SYNTAX II Trial

Taku Asano, Yuki Katagiri, Chun Chin Chang, +19

JACC: Cardiovascular Interventions

Vascular ImageCardiovascular DiseaseCardiologySyntax Ii TrialPublic Health +5

Joint consensus on the use of OCT in coronary bifurcation lesions by the European and Japanese bifurcation clubs

Yoshinobu Onuma, Yuki Katagiri, Francesco Burzotta, +10

EuroIntervention

SurgeryCoronary Artery DiseaseAcute Myocardial InfarctionAtherosclerosisCardiology +19